Thorne HealthTech Inc - THRN Net earnings per share growth forecast for next year

Public company logo of thorne.com (THRN)

Thorne HealthTech management effectively protected the brand by taking the personalized nutraceuticals platform private under the aegis of L Catterton. Next year's EPS outlook reflects current market expectations, with the value fixed at 0.60. US-based dietary supplement production capacities ensure stability through a scientific approach. A loyal customer base and the fund's support have created an insurmountable barrier for new entrants.

THRN: Thorne Research Expected net earnings per share growth next year 07/04/2022 - 10/21/2023

thorne.com - analytical breakdowns and key metrics (THRN)

- price and consensus price forecast:
Price Chart Thorne|THRN - Fair Value Consensus
- issuer market value details:
Market Value Thorne HealthTech|THRN - Business Value
- company book value details:
Book Value per Share Thorne HealthTech|THRN - Total Stockholders' Equity|Market Cap to Net Assets Ratio thorne.com|THRN - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Thorne HealthTech|THRN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Thorne HealthTech, Inc.|THRN - Company Cumulative Debt|Debts to Book Capitalization Thorne HealthTech|THRN - Company Long-Term Debts|Company Short-Term Debt Thorne HealthTech|Quick Liquidity Indicator thorne.com
- earnings and valuation multiples information:
THRN - Profit After Payment of Taxes|Projected Future Earnings Thorne HealthTech|THRN - Company Value to Net Income|Projected Price to Earnings Thorne HealthTech|THRN - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Thorne HealthTech|THRN - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Thorne HealthTech|THRN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth thorne.com|THRN - Earnings per share increase in current year|Expected earnings per share growth for next year Thorne HealthTech
Fundamental company analysis:Thorne, THRN
Finished products of thorne.com

Defensive assets are selected based on the stability of earnings against market shocks, which is particularly relevant for Thorne HealthTech (THRN) amid the expansion of the personalized medicine segment and its transition to private status. This forward-looking net income trajectory aggregates expert consensus forecasts for EPS dynamics, allowing investors to assess the business's current margin of safety and the extent to which operational risks are priced into the market value.

Main competitors

Net earnings per share growth forecast for next year Hims|HNGE: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Teladoc Health, Inc. (TDOC)|talkspace.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year LFMD (LifeMD)|American Well Corporation (AMWL) - Expected net earnings per share growth next year|MGRX: Expected earnings per share growth for next year|Expected earnings per share trend next year DRIO (DarioHealth Inc)|VSEE: Earnings growth forecast for next year|manadr.com - Expected earnings per share trend next year|ACCD (Accolade Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Biotricity Inc. BTCY|Earnings growth forecast for next year LYT|Earnings growth forecast for next year Ontrak Corp (OTRK)|Net earnings per share growth forecast for next year SHL Telemedicine SHLT